Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
David R. Lewis
Should Johnson & Johnson Break Up?
Morgan Stanley Sees Brighter View On 2016 Emerging For Stryker
Morgan Stanley Reiterates Overweight, Raises PT On Boston Scientific On Path To 2017
Morgan Stanley Sees Brighter View On 2016 Emerging For Stryker
Morgan Stanley Reiterates Overweight, Raises PT On Boston Scientific On Path To 2017
3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis
Morgan Stanley Sees Expansion Case Continue For Medtronic
3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis
Morgan Stanley Sees Expansion Case Continue For Medtronic
Morgan Stanley Sees 2015 As Execution Year For Intuitive Surgical
Morgan Stanley Analyst Sees FY15 'Trough' For Johnson & Johnson Pharma Growth
Read More...
David R. Lewis Recent News
Morgan Stanley Sees Balance Sheet & Pipeline As More Critical For Johnson & Johnson
UPDATE: Morgan Stanley Raises PT On Edwards Lifesciences Corp., Say Upside Now Tied To Bull Case
UPDATE: Morgan Stanley Reiterates On Nevro On Improving Margins
Morgan Stanley Believes That Delays Temper Enthusiasm For Intuitive Surgical
UPDATE: Morgan Stanley Reiterates On Baxter International On Value Creation Through Spin
Morgan Stanley: CareFusion Corporation Deal Offers 'Good, Not Great' Returns For Becton, Dickinson And Co.
Morgan Stanley Sees Ways For Medtronic, Inc. To Create Value
UPDATE: Morgan Stanley Reiterates On Medtronic, Inc. On Proposed Treasury Rules
Morgan Stanley Remains Positive On Stryker Corporation
Morgan Stanley Has Critical Questions For Stryker Corporation Going Into Investor Day
Morgan Stanley Sees Johnson & Johnson Taking Rx Estimates Higher
Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson
Morgan Stanley Sees Attractive Risk/Reward For Medtronic
Morgan Stanley Sees US Market Acceleration Driving Upside Potential For Edwards Lifesciences
Morgan Stanley Ponders How Potential Danone Acquisition Could Affect Hospira
Morgan Stanley Modestly Adjusts Share Assumptions For Edwards Lifesciences
UPDATE: Morgan Stanley Reiterates On Abbott Laboratories As Growth and Margins Are Set To Continue
Morgan Stanley Sees Meaningful '15 Headwind For Johnson & Johnson
Morgan Stanley Sees Underappreciated Upside Drivers For Zimmer
Morgan Stanley Sees Execution Priced In For Becton, Dickinson and Co.
Morgan Stanley Sees Growth Acceleration As Key To Thesis For Abbott Laboratories
Morgan Stanley Sees End-Market Pressure On Hill-Rom
UPDATE: Morgan Stanley Upgrades Medtronic Following Acquisition Of COV